A record-high number of Americans say they have tried a weight-loss drug, a new national poll from Gallup found. The survey ...
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program that launches July 1.
The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.
A new pilot program will expand access to weight loss treatments beginning July 1. Officials say eligible Medicare enrollees ...
For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs. Now ...
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...
The program, which will make weight loss drugs eligible for people on Medicare for $50 a month, is set to run for only 18 ...
Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...
GLP-1 weight-loss drugs will cost $50 a month for many older adults starting July 1, as Medicare begins to cover them. How the Medicare GLP-1 Bridge plan works.
GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out if you qualify.